Log in to save to my catalogue

The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma recei...

The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma recei...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5d27a41c30724b90858c7fbb9dde10ad

The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Nephrectomy is considered the backbone of managing patients with localized and selected metastatic renal cell carcinoma (mRCC). The prognostic role of nephrectomy has been widely investigated with cytokines and targeted therapy, but it is still unclear in the immunotherapy era.
We investigated the Meet-URO-15 study dataset of 571 pretreated mRCC...

Alternative Titles

Full title

The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5d27a41c30724b90858c7fbb9dde10ad

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5d27a41c30724b90858c7fbb9dde10ad

Other Identifiers

ISSN

1479-5876

E-ISSN

1479-5876

DOI

10.1186/s12967-022-03601-6

How to access this item